argenx SE (ARGX)
FDA Applications
Note: This list only includes applications that have been responded to by the FDA.
| Application | Product Name | Active Ingredient | Form | Strength | Status | ||
|---|---|---|---|---|---|---|---|
| BLA761304 - ARGENX BV | |||||||
| VYVGART HYTRULO | EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC | INJECTABLE;INJECTION | 1008MG;11200UNITS PER 5.6ML | Prescription | |||
| BLA761195 - ARGENX BV | |||||||
| VYVGART | EFGARTIGIMOD ALFA | INJECTABLE;INJECTION | 400MG | Prescription | |||